Monozygotic twins with neuroblastoma MS have a similar molecular profile: a case of twin-to-twin metastasis
-
Published:2019-10-11
Issue:10
Volume:121
Page:890-893
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Shatara MargaretORCID, Xavier Ana C., Dombkowski Alan, Cukovic Daniela, Poulik Janet M., Altinok Deniz, Ge Yubin, Taub Jeffrey W.
Abstract
Abstract
Fetoplacental neuroblastoma metastasis has been postulated as a mechanism accounting for concordant cases where one twin develops a primary tumour and the second twin manifests the disease without an identifiable primary site. These tumours may originate and spread concomitantly due to the same genetic background shared by monozygotic twins. This study investigated the molecular profile of stage MS neuroblastoma presenting concomitantly in monozygotic twins. Comparative genomic hybridisation (aCGH) was done for each of the twin liver tumour and peripheral blood samples at diagnosis. Comparison of copy-number variation (CNV) regions revealed a set of CNVs that were common to both tumour specimens and not apparent in the blood. The CNV signature in both twins’ tumours was highly similar, suggesting a common clonal origin. Additional findings included large deletion of chromosome 10 and amplification of chromosome 17. Notably, both liver samples had amplification of a short region involving DEIN (chromosome 4q34.1). Similar CNVs strongly support a common clonal origin and metastatic spread from one twin to the other. DEIN is a long-coding RNA (IncRNA) that has been found highly expressed in stage MS neuroblastoma and is likely involved in biological processes such as cell migration and metastasis.
Funder
Children's Hospital of Michigan Foundation Justin’s Gift Charity
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference17 articles.
1. Abu-Arja, R., Hashem, H., El-Sheikh, A. & Abusin, G. Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis. Pediatr. Blood Cancer 61, 1124–1125 (2014). 2. Tajiri, T., Souzaki, R., Kinoshita, Y., Tanaka, S., Koga, Y., Suminoe, A. et al. Concordance for neuroblastoma in monozygotic twins: case report and review of the literature. J. Pediatr Surg. 45, 2312–2316 (2010). 3. Kreissman, S. G., Seeger, R. C., Matthay, K. K., London, W. B., Sposto, R., Grupp, S. A. et al. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 14, 999–1008 (2013). 4. Agilent Technologies I. Agilent Oligonucleotide Array-Based CGH for Genomic DNA Analysis. ULS Labeling for Blood, Cells, Tissues, or FFPE (with a High Throughput option). Agilent.com. Protocol Version 2015 Aug, 3.5:1–94 (2015). 5. Theissen, J., Oberthuer, A., Hombach, A., Volland, R., Hertwig, F., Fischer, M. et al. Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma. Genes Chromosomes Cancer 53, 639–649 (2014).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|